ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 424,25
-0,32%
DAX
21 394,93
-0,11%
Brent Oil
77,03
-0,20%
Bitcoin
100 917,35
-1,70%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Personalis Inc (PSNL) Cours

Personalis Inc

Personalis Inc (PSNL)

Persimmon PLC
Persimmon PLC
Persimmon PLC
6,12
-0,03
(-0,49%)
Fermé 27 Janvier 10:00PM
Retardé de 15 minutes
6,05
-0,07
(-1,14%)
Après les heures de négociation: 1:29AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
6,05
Prix Achat
6,02
Prix Vente
6,16
Volume échangé
1 224 902
5,92 Fourchette du Jour 6,2737
1,12 Plage de 52 semaines 7,20
Cap du marché
427,421M
Clôture Veille
6,15
Ouverture
6,27
Dernière Transaction
596
@
6.05
(formt)
Dernière heure de transaction
Volume financier
US$ 7 487 868
VWAP
6,113
Volume moyen (3 m)
1 099 004
Actions en circulation
70 648 084
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,99
Bénéfice par action (BPA)
-1,53
Chiffre d'affairess
73,48M
Bénéfice net
-108,3M

À propos de Personalis Inc

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT... Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. Show more

Secteur
Medical Laboratories
Industrie
Medical Laboratories
Site Web
www.personalis.com
Siège social
Dover, Delaware, USA
Fondé
-
Personalis Inc est coté dans le secteur Medical Laboratories de la NASDAQ avec le ticker PSNL. Le dernier cours de clôture d'Personalis était de US$6,15. Au cours de la dernière année, les actions de Personalis ont été négociées dans une fourchette de prix de US$ 1,12 à US$ 7,20.

Personalis compte actuellement 70 648 084 actions en circulation. La capitalisation boursière d'Personalis est de US$434,49 million. Personalis a un ratio cours/bénéfice (ratio PE) de -3.99.

PSNL Dernières nouvelles

Plus de nouvelles

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

Results demonstrate the importance of ultra-sensitive ctDNA detection in lung cancer Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at...

13 Janvier 2025
Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

11 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

Full year revenue of ~$84.6 million represents a 15% year-over-year increase Cash balance of ~$185.0 million expected to provide runway to cash flow break-even Personalis, Inc. (Nasdaq: PSNL), a...

07 Janvier 2025
Business Wire

Form 8-K - Current report

27 Décembre 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

27 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 Décembre 2024
Edgar (US Regulatory)

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Personalis, Inc. (NASDAQ: PSNL) announced today agreements with long time collaborators Merck and Moderna that accelerate the advancement of the company’s business strategy. The company has...

19 Décembre 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.2726.56903765694.786.124.711136055.47275082CS
4-0.24-3.815580286176.296.984.710046965.6991826CS
120.9919.56521739135.067.193.2810990045.00052338CS
263.31202.757.22.6410450124.9973275CS
524.4266.6666666671.657.21.128012444.10221448CS
156-3.58-37.17549325039.6312.960.89065629333.84263929CS
260-5.57-47.93459552511.6253.460.890656977012.0434197CS

PSNL - Frequently Asked Questions (FAQ)

What is the current Personalis share price?
The current share price of Personalis is US$ 6,05
How many Personalis shares are in issue?
Personalis has 70 648 084 shares in issue
What is the market cap of Personalis?
The market capitalisation of Personalis is USD 434,49M
What is the 1 year trading range for Personalis share price?
Personalis has traded in the range of US$ 1,12 to US$ 7,20 during the past year
What is the PE ratio of Personalis?
The price to earnings ratio of Personalis is -3,99
What is the cash to sales ratio of Personalis?
The cash to sales ratio of Personalis is 5,87
What is the reporting currency for Personalis?
Personalis reports financial results in USD
What is the latest annual turnover for Personalis?
The latest annual turnover of Personalis is USD 73,48M
What is the latest annual profit for Personalis?
The latest annual profit of Personalis is USD -108,3M
What is the registered address of Personalis?
The registered address for Personalis is 3500 SOUTH DUPONT HIGHWAY, DOVER, DELAWARE, 19901
What is the Personalis website address?
The website address for Personalis is www.personalis.com
Which industry sector does Personalis operate in?
Personalis operates in the MEDICAL LABORATORIES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
PSNL
Personalis
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés